Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Can Johnson & Johnson Navigate Its Public Relations Tightrope?
Wall St. Cheat Sheet
Friday, May 17, 2013 - 10:43am
tags:
JNJ
AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
Yahoo/Reuters
Friday, May 17, 2013 - 10:43am
tags:
Galapagos, AbbVie, GLPG0634, Crohn's Disease
Halozyme rises on pancreatic cancer drug study
Yahoo/AP
Thursday, May 16, 2013 - 5:30pm
tags:
pancreatic cancer, Halozyme, PEGPH20
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
Reuters
Thursday, May 16, 2013 - 5:28pm
tags:
Roche, M&A, Novartis, Daniel Vasella
J&J Will Stop Sales of Metal-on-Metal Hip Replacements
Bloomberg
Thursday, May 16, 2013 - 5:23pm
tags:
JNJ, hip implants, recalls, devices
New Study Reports Key Findings for the ABThera™ Open Abdomen Negative Pressure Therapy System
CP Wire
Thursday, May 16, 2013 - 4:57pm
tags:
open abdomen surgery, Kinetic Concepts, ABThera, devices
With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What
Forbes
Thursday, May 16, 2013 - 11:07am
tags:
Bristol-Myers Squibb, Merck, Roche, Ono Pharmaceuticals, Yervoy, nivolumab
X-Spine wins FDA clearance for spinal fusion system
Mass Device
Thursday, May 16, 2013 - 10:40am
tags:
FDA, spinal fusion, X-spine, devices, Zygafix
ASCO '13 Preview: Oncothyreon's Failed Lung Cancer Vaccine
TheStreet.com
Thursday, May 16, 2013 - 10:38am
tags:
ASCO, lung cancer, vaccines, Oncothyreon, Stimuvax, Merck KGaA
Neuralstem Rounding Second With Phase II ALS Trial
Seeking Alpha
Thursday, May 16, 2013 - 10:35am
tags:
ALS, Neuralstem, stem cells
AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials
Bloomberg
Thursday, May 16, 2013 - 10:33am
tags:
AstraZeneca, moxetumomab pasudotox, hairy cell leukemia, olaparib, ovarian cancer, selumetinib, non-small cell lung cancer
BioMarin abstract showed impressive anti-tumor activity, says Leerink
Yahoo/Fly on the Wall
Thursday, May 16, 2013 - 10:28am
tags:
Biomarin, BMN-673, solid tumors
Lundbeck Jumps as Depression Drug Gets Praise
Bloomberg
Thursday, May 16, 2013 - 10:26am
tags:
Lundbeck, Brintellix, antidepressants
Investing In Increased Tattoo Removal With Cynosure
Seeking Alpha
Thursday, May 16, 2013 - 10:25am
tags:
tattoo removal, Cynosure, devices
Jury is out in another case linking Novartis' Zometa to jawbone death
Fierce Pharma
Thursday, May 16, 2013 - 10:23am
tags:
Zometa, Novartis
Roche immunotherapy shows response over range of cancers
Reuters
Thursday, May 16, 2013 - 10:22am
tags:
Roche, immunotherapy, MPDL3280A, melanoma, lung cancer, kidney cancer
Johnson & Johnson, Medtronic Frontrunners In Race To Develop Artificial Pancreas
Seeking Alpha
Thursday, May 16, 2013 - 10:20am
tags:
JNJ, Medtronic, devices, artificial pancreas, type 1 diabetes
Zoetis' Apoquel for allergic dogs approved by FDA
The Fly on the Wall
Thursday, May 16, 2013 - 10:18am
tags:
FDA, animal health, Zoetis, Apoquel
Novartis says no intention of pursuing Actavis, Bloomberg reports
Yahoo/Fly on the Wall
Thursday, May 16, 2013 - 10:17am
tags:
Actavis, Novartis, M&A
Theravance Looks to Reward Shareholders by Splitting Into Two Distinct Companies
Motley Fool
Thursday, May 16, 2013 - 9:01am
tags:
Theravance

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.